Brief: Crescita Therapeutics Q2 Revenue C$2.3 Mln Versus C$4.9 Mln
10/08/2018 12:38
Aug 10 (Reuters) - Crescita Therapeutics Inc CTX.TO :
* CRESCITA THERAPEUTICS™ REPORTS 2018 SECOND QUARTER RESULTS
* Q2 REVENUE C$2.3 MILLION VERSUS C$4.9 MILLION
* QTRLY NET LOSS FROM CONTINUING OPERATIONS PER SHARE C$0.03
Source text for Eikon: urn:newsml:reuters.com:*:nCNW8BmMra
Further company coverage: CTX.TO
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Crescita Therapeutics
See all newsBrief: Crescita Therapeutics Obtains Shareholder Approval To Be Acquired By Clinactiv Holdings
Canada's Crescita Q1 revenue rises on manufacturing growth
Canada's Crescita Q4 revenue falls on prior-year one-time reimbursement
Brief: Crescita Reports Q4 And Fiscal 2025 Results
Brief: Crescita Announces Definitive Agreement To Be Acquired By Clinactiv Holdings In An All-Cash Transaction At A Significant Premium